- $5.13bn
- $5.38bn
- $1.17bn
Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
Brief: Trex Company Announces September 2026 Investor Conference Schedule
Trex Company Inc reports results for the quarter ended June 30 - Earnings Summary
Trex Company Q2 sales beat estimates, driven by volume growth
Brief: Trex Company Q2 Adjusted EPS USD 0.62 Vs. IBES Estimate USD 0.63
Brief: Trex Company Upgrades Distribution Network Raises Full Year Guidance
Trex Q1 sales rise 1%, adjusted profit beats estimates
Brief: Trex Company Appoints Zachary C. Lauer As Chief Operations Officer
Brief: Trex Company Announces $100 Million Accelerated Share Repurchase
Brief: Trex Company Announces CEO Succession Plan
Trex Q4 sales exceed expectations, adjusted EPS beats
Brief: Trex Company Q4 Adjusted EPS USD 0.04 Vs. IBES Estimate USD -0.02
Brief: Trex Showcases The Future Of Outdoor Living At IBS 2026
Brief: Trex Company Appoints Irene Tasi To Board Of Directors
Brief: Trex Expands Distribution Collaboration With SBP in the Midwest
James Hardie's Australian shares tumble 13% as MSCI cuts index listing
U.S. STOCKS ON THE MOVE-Targa Resources, Illumina, Alphabet
U.S. STOCKS ON THE MOVE-Bunge, O'Reilly Automotive, Targa Resources
U.S. STOCKS ON THE MOVE-Lemonade, New York Times, Johnson Controls